| 25.07 15:33 | dpa-AFX: *EDWARDS LIFESCIENCES -28% - GRÖSSTER TAGESVERLUST SEIT 2000 |
| 25.07 14:37 | dpa-AFX: Pre-market Movers: PBM, TWOU, IROQ, MIRA, POAI. |
| 25.07 14:15 | dpa-AFX: *EDWARDS LIFESCIENCES FALLEN VORBÖRSLICH BIS ZU 25% |
| 25.07 13:23 | dpa-AFX: ANALYSE-FLASH/GS senkt Ziel für Edwards Lifesciences, Wachstumsdebatte angeheizt |
| 25.07 13:08 | dpa-AFX: *GOLDMAN SENKT ZIEL FÜR EDWARDS LIFESCIENCES AUF 91 (107) USD - 'BUY' |
| 25.07 13:08 | dpa-AFX: *GOLDMAN CUTS EDWARDS LIFESCIENCES PRICE TARGET TO 91 (107) USD - 'BUY' |
| 25.07 11:54 | dpa-AFX: *TRUIST SECS SENKT EDWARDS LIFESCIENCES AUF 'HOLD' - ZIEL 82 USD |
| 25.07 11:54 | dpa-AFX: *TRUIST SECS CUTS EDWARDS LIFESCIENCES TO 'HOLD' - PRICE TARGET 82 USD |
| 25.07 11:36 | dpa-AFX: ANALYSE-FLASH/JPM: Edwards Lifesciences geht 'zwei Schritte zurück' bei TAVR |
| 25.07 10:55 | dpa-AFX: *JPMORGAN SENKT EDWARDS LIFESCIENCES AUF 'NEUTRAL' (OW) - ZIEL 72 (105) USD |
| 25.07 10:55 | dpa-AFX: *JPMORGAN CUTS EDWARDS LIFESCIENCES TO 'NEUTRAL' (OW) - PRICE TARGET 72 (105) USD |
| 25.07 08:27 | dpa-AFX: *EDWARDS LIFESCIENCES BEI TG -21,5% - KAPPEN AUSBLICK FÜR AORTENKLAPPENIMPLANTATE |
| 24.07 22:46 | dpa-AFX: Edwards Lifesciences Corp. Q2 Profit Increases, Beats Estimates |
| 24.07 22:46 | dpa-AFX: *EDWARDS LIFESCIENCES Q2 EPS $0.61 VS. $0.50 YEAR AGO |
| 24.07 22:46 | dpa-AFX: *EDWARDS LIFESCIENCES Q2 NET SALES $1.39 BLN VS. $1.30 BLN LAST YEAR |
| 24.07 12:34 | dpa-AFX: Edwards Lifesciences Q2 24 Earnings Conference Call At 5:00 PM ET |
| 15.07 15:10 | dpa-AFX: Edwards Lifesciences To Acquire Innovalve Bio Medical |
| 15.07 15:04 | dpa-AFX: *EDWARDS LIFESCIENCES TO ACQUIRE INNOVALVE BIO MEDICAL |
| 03.06 12:56 | dpa-AFX: Edwards Lifesciences Stock Up With BD Deal To Buy Critical Care Product Unit For $4.2 Bln Cash |
| 03.06 12:37 | dpa-AFX: *BD TO ACQUIRE CRITICAL CARE FOR $4.2 BLN, SEES DEAL TO CLOSE BEFORE END OF CALENDAR YEAR |
|
|
